Wireless Microphone Market Set to Witness an Uptick during 2018 to 2025

The global wireless microphone market is estimated to reach USD 3.51 billion by 2025, growing at a CAGR of 5.9%, according to a new study by Grand View Research, Inc. Technological proliferation such as Wi-Fi and Bluetooth enabled microphones are expected to drive the market growth over the forecast period.

The evolving entertainment and media industry, mainly in developing regions such as Asia Pacific and Latin America, has fostered the demand for wireless microphone products. These products are used for applications such as television broadcasting, public speaking, podcasting, and performing arts. The preference for wireless microphones has increased among consumers as these microphones enable performers to move their hands freely, thereby increasing comfort.

The adoption of wireless microphones is anticipated to grow in the Asia Pacific region. Global sports events such as Summer Olympics 2020 and Winter Olympics 2022 are scheduled to be organized in the region, which is presumed to propel the demand for wireless microphones. Furthermore, the increasing application of microphones in government infrastructure is expected to boost the adoption of wireless microphones in the Asia Pacific region.

The changing regulatory scenario of wireless spectrum across regions including North America and Europe is expected to propel the market growth. It enables market participants to develop new products that comply with the new spectrum regulations. Moreover, the new products are developed to provide features such as efficient audio signal transmission and high output audio quality.

Prominent & established industry players and new entrants collaborate with each other for sharing expertise and resources. The market is highly competitive and major companies are laying emphasis on retaining their market shares. Moreover, there is a strong presence of small and local manufacturing companies in the market, mainly in countries such as China and Japan.

Access Research Report of Wireless Microphone Market @: www.grandviewresearch.com/industry-analysis/wireless-microphone-market

Further key findings from the study suggest:

• The clip-on segment is expected to emerge as the fastest growing segment, registering a CAGR of 6.8% over the forecast period. Increasing public speaking events are encouraging the demand for this segment.
• The North American region has announced changes in regulations wherein the use of wireless frequency is restricted to below 600 MHz. Any device operating above 600 MHz would be illegal.
• Radio Frequency (RF) band is the fastest growing segment, registering a CAGR of 7.5% over the next eight years. The RF band offers a large number of frequency options that facilitate the selection of frequency depending on the application.
• Asia Pacific is estimated to be the fastest-growing regional market due to the growth of sports and entertainment events in the region leading to an increase in demand for audio equipment
• Key industry participants include AKG Acoustics, Audio-Technica Corporation, Blue, LEWITT GmbH, Rode Microphones, Samson Technologies Inc., Sennheiser Electronic GmbH & Co., Shure Incorporated, Sony Electronics, Inc., and Yamaha Corporation, among others

Grand View Research has segmented the global wireless microphone market based on types, technology, end uses, and regions:

Wireless Microphone Type Scope (Revenue, USD Million; 2014 - 2025)

• Handheld
• Clip-on
• Others

Wireless Microphone Technology Scope (Revenue, USD Million; 2014 - 2025)

• Wi-Fi Band
  • 4 GHz
  • 6 GHz
  • 5 GHz
• Radio Frequency Channel
  • Single Channel
  • Dual Channel
  • Multi-Channel
• Radio Frequency band
  • 540 MHz - 680 MHz
  • 721 MHz - 750 MHz
  • 823 MHz - 865 MHz

Wireless Microphone End-use Scope (Revenue, USD Million; 2014 - 2025)

• Corporate
• Education
• Hospitality
• Sporting Events
• Others

Wireless Microphone Regional Scope (Revenue, USD Million; 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Attractive Market Opportunities in the Continuous Renal Replacement Therapy Market by 2025

The global continuous renal replacement therapy (CRRT) market size is expected to reach USD 1.4 billion by 2025, according to a new report by Grand View Research, Inc. The magnitude of the global target diseases, such as kidney diseases, and diabetes, is immense, with millions of new cases registered every year. This in turn is anticipated to boost the usage of CRRT treatment procedure.

Increasing the incidence of volume overload, uremia, and hyperkalemia is increasing the application of renal replacement therapy, thereby boosting the overall growth of the market. For individuals suffering from acute kidney injury and severe multi-organ dysfunction, CRRT can prove to be beneficial when started early to maintain metabolic and volume homeostasis. In addition, CRRT prevents further worsening and development of symptoms and signs of renal failure.  

To request a sample copy or view summary of this report, click the link below:http://www.grandviewresearch.com/industry-analysis/continuous-renal-replacement-therapy-crrt-market

Further Key Findings From the Study Suggest:

• The continuous renal replacement therapy market study suggests that the consumables segment dominated the overall market in 2016.  The factors triggering the growth the segment are increasing application of hemofilter, fluids, charcoal filters and others consumables in CRRT
• Moreover, constant repeat purchase of consumables due to their one-time use is adding up to the revenue generation for the segment
• Amongst the modality segments, continuous venovenous hemofiltration (CVVH) occupied the largest share in 2016. Increasing the incidence of fluid overload cases which is frequently found in acute kidney injury patients in critical care units would boost the growth of the CVVH market.
• The continuous venovenous hemodiafiltration (CVVHDF) segment is expected to grow at the highest growth rate during the forecast period.  CVVHDF is associated with improved survival rate when compared to other CRRT modalities due to a combination of principles of diffusion and convection, i.e., hemofiltration and hemodialysis using a highly efficient hemodiafilter to remove both solute and fluid.
• North America accounted for the largest share in 2016, due to the increasing prevalence of kidney disorders, and congestive heart failure in the region.
• In addition, increasing incidences of acute kidney injury cases leading to increased creatinine levels, hyperkalemia, and uremia are a few high impact-rendering drivers for the market in North America.
• The Asia Pacific is expected to foresee significant growth during the forecast period. The high-unmet medical needs pertaining to the target disease segment, such as diabetes, hypertension, and chronic kidney disease, coupled with constantly improving healthcare expenditure in the region are some of the key factors attributing to market growth
• Some of the major companies operating in this market are B. Braun Melsungen AG, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, NIPRO Corporation, Toray Medical Co., Ltd, NxStage Medical, Inc., Medtronic plc, and others.

Grand View Research has segmented the global continuous renal replacement therapy market on the basis of product, modality, and region:

Continuous Renal Replacement Therapy Product Outlook (Revenue, USD Million, 2014 - 2025)

• System
• Consumables

Continuous Renal Replacement Therapy Application Outlook (Revenue, USD Million, 2014 - 2025)

• Slow continuous ultrafiltration
• Continuous venovenous hemofiltration
• Continuous venovenous hemodialysis
• Continuous venovenous hemodiafiltration

Continuous Renal Replacement Therapy Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The U.K.
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Genome Editing Market New Opportunities For Industry Growth And Forecast To 2025

The Report Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2018 – 2025

The global genome editing market is anticipated to reach USD 8.1 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

The ability of genome editing therapies to offer a significant improvement over current treatment options is important in enabling editing technologies to capture significant revenue share. Improved efficacy, reduced side effects, and the potential for cure for specific diseases, can be attributed to induce growth in the coming years. 

Moreover, technological advancements with respect to the development of novel vectors for delivery is anticipated to fuel growth in the coming years. Rising competition amongst the operating entities in order to gain the larger share of revenue is also responsible for the projected growth. These companies leverage industry collaborations for the acceleration of diversified product pipelines. 

Access Research Report of Genome Editing Market @ www.grandviewresearch.com/industry-analysis/genome-editing-market

Further Key Findings from the Report Suggest:

• There has been great excitement surrounding the highly adaptable CRISPR technology.
• The increased ease of retargeting and the ability to multiplex goes a long way toward explaining the speed with which CRISPR-centric companies have sprung up.
• Ex-vivo mode of delivery accounted for the largest share of the revenue.
• Therapy through ex-vivo mode of delivery allow the control over the specific dosage of therapeutic molecules delivered to cells.
• Cell line engineering dominated with respect to revenue generation owing to the high utilization of technology in stem cell engineering.
• There is comparatively, higher adoption of the technology in the biotechnology and pharmaceutical organizations for the purpose of therapeutic development.
• Availability of other services such as gRNA library production and screening service along with editing is anticipated to propel growth in the outsourcing services.
• Asia Pacific is anticipated to witness fastest growth over the forecast period owing to rising penetration of technology in comparatively immature market.
• Key players contributing in this market are Thermo Fisher Scientific, Inc., Sangamo, Editas Medicine, Recombinetics, Inc, Sigma Aldrich Corporation, CRISPR THERAPEUTICS, Intellia Therapeutics, Inc., Caribou Biosciences, Inc.
• These participants are capitalizing on unique advantages offered by the nuclease technology, they are working on.

Grand View Research has segmented the molecular scissors/genome editing market on the basis of technology, delivery method, application, end-use, service, and region: 

Molecular Scissors/Genome Editing Technology Outlook (Revenue, USD Million, 2014 - 2025)

• (CRISPR)/Cas9
• TALENs/MegaTALs
• ZFN
• Others

Molecular Scissors/Genome Editing Delivery Method Outlook (Revenue, USD Million, 2014 - 2025)

• Ex-Vivo
• In-Vivo

Molecular Scissors/Genome Editing Application Outlook (Revenue, USD Million, 2014 - 2025)

• Cell Line Engineering
• Animal Genetic Engineering
• Plant Genetic Engineering
• Other Applications

Molecular Scissors/Genome Editing End-use Outlook (Revenue, USD Million, 2014 - 2025)

• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Contract Research Organizations

Molecular Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)

• Contract
• In-house

Molecular Scissors/Genome Editing Service Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Disposable Blood Pressure Cuffs Market is Estimated to Register a Strong CAGR of 13.6% during the Forecast Period

The Report Disposable Blood Pressure Cuffs Market Analysis By Call Points (Surgeons, Physician, Clinicians), By Region (North America, Europe, Asia Pacific, Latin America, MEA) And Segment Forecasts, 2018 – 2025

The global disposable blood pressure cuffs market is expected to reach USD 356.8 million by 2025, according to a new study by Grand View Research, Inc. The market is driven by the growing adoption of disposable BP cuffs by healthcare professionals to avoid the risk of cross-contamination. In addition, there is a significant rise in the occurrence of infections at hospitals over the past two decades, which has created a momentum in the implementation of infection control policies in order to reduce the incidence of hospital-acquired infections.

Moreover, the introduction of technologically advanced products is attributing towards the growth. These products are meeting all the regulatory requirements and available at an affordable cost which thereby boosting the usage rates in coming years. For instance, GE CRITIKON BP Cuffs offered by GE Healthcare meeting all the sizing standards of the American Heart Association to take accurate blood pressure readings. The aforementioned factors are presumed to fuel the growth over the forecast period.

Access Research Report of Disposable Blood Pressure Cuffs Market @ www.grandviewresearch.com/industry-analysis/disposable-blood-pressure-cuffs-market

Further Key Findings From The Study Suggest:

• Clinicians call point segment is expected to show lucrative growth in coming years due to rising patient population visited clinics for the regular monitoring of blood pressure
• The existing industry participants are actively involved in the development of customized & specialized blood pressure monitoring products, to sustain the competition
• Introduction of digital sphygmomanometer and mHealth technology, which is expected to impede the growth in coming years as they used as a substitute for these products
• Furthermore, introduction of antimicrobial reusable BP cuffs which gives accurate results and offers enhanced safety to the patients may hamper the growth
• The Asia Pacific regional market for disposable BP cuffs is expected to showcase significant growth over the forecast period owing to supportive government initiatives for increasing awareness amongst people and rapidly growing target disease population base
• In addition, improving healthcare facilities is propelling the further growth in the near future. In addition, cheaper cost of disposable products is expected to provide this market with lucrative growth opportunities in the near future

Grand View Research has segmented the disposable blood pressure cuffs market on the basis of call point, and region: 

Disposable Blood Pressure Cuffs Call Point Outlook (Revenue, USD Million, 2014 - 2025)

• Surgeons
• Physicians
• Clinicians

Disposable Blood Pressure Cuffs Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nucleic Acid Amplification Test Market is Likely To Touch USD 4.4 Billion by 2025

Nucleic Acid Amplification Test Market Growth & Trends

The global nucleic acid amplification testing market size is expected to reach USD 4.4 Billion by 2025, according to a new report by Grand View Research, Inc. Nucleic acid amplification testing is gaining preference over traditional diagnostic techniques because of its high efficiency and accuracy. In addition, the potential application of these tests in various life-threatening diseases, including several types of cancer, is attracting a large amount of investment for the purpose of R&D. Increasing number of ongoing studies are expected to ensure higher growth rate in the later part of the forecast period.

These tests are currently being used extensively for screening and diagnosis of a wide range of infectious diseases. Along with known infectious diseases, management of epidemics of new diseases has caused a sudden surge in the demand for advanced diagnostic tests. NAAT is currently the most advanced and efficient diagnostic method, which extensively uses technology that helps in reducing procedural time and consumption of reagents.

Request a free sample copy or view report summary: Nucleic Acid Amplification Test Market Report

Nucleic Acid Amplification Test Market Report Highlights

• The market study suggests that infectious diseases segment captured the largest revenue share in 2015 owing to the high demand for effective screening methods for management of these diseases
• Cancer is expected to exhibit the fastest growth during the forecast period due to the rising number of studies to develop tests for early detection of various cancer types
• Expanding applications prenatal screening and for the detection of mitochondrial disorders is expected to boost the demand for NAAT
• High usage of the PCR technique in NAT is driving the growth of the segment and is expected to capture significant revenue share in the near future
• North America dominated the space in 2015 with U.S. capturing the largest share
• Evolution of biotechnology sector in the Asia Pacific, along with the favorable government initiatives, Asia Pacific is expected to show the fastest growth rate during the forecast period
• A few of the major players in the market are F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Becton, Dickinson and Company; Novartis AG; Beckman Coulter, Inc.; bioMérieux SA; Abbott Laboratories; Siemens Healthineers, and Illumina, Inc.

Nucleic Acid Amplification Test Market Segmentation

Grand View Research has segmented the nucleic acid amplification test market on the basis of application, technique, and region:

Nucleic Acid Amplification Test Application Outlook (Revenue, USD Million, 2014 - 2025)

• Infectious Diseases
  • Virus
  • Bacteria
  • Others
• Cancer
• Personalized Medicine
• Genetic and Mitochondrial Disorders

Nucleic Acid Amplification Test Technique Outlook (Revenue, USD Million 2014 - 2025)

• Target amplification systems
• Probe amplification systems
• Signal amplification

Nucleic Acid Amplification Test Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Germany Asia Pacific
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Hemodialysis & Peritoneal Dialysis Market is Expected to Grow with CAGR of 6.0% over the Forecast Period

The global hemodialysis and peritoneal dialysis market is expected to reach USD 108.5 billion by 2025, according to a new report by Grand View Research, Inc. Home-based dialysis treatment is anticipated to witness lucrative growth over the forecast period. Factors supporting this trend include; increasing development of small and automated products capable of providing treatment at home, rising number of individuals requiring daily procedures, growing number of individuals aptly trained to perform self-treatment, and initiatives by market participants toward raising education and training for home dialysis performance.

This industry is highly competitive with a few players holding relatively high proportion of the market share. However, the dominance of each player is in a separate region thereby limiting direct competition. For instance, Baxter generates higher revenue in Europe whereas Fresenius Medical Care AG & Co. KGaA gains higher revenue in the U.S. This scenario is anticipated to change over the forecast period owing to increasing globalization, and efforts by companies to expand their revenues and profits.

Access Research Report of Hemodialysis & Peritoneal Dialysis Market @ www.grandviewresearch.com/industry-analysis/hemodialysis-peritoneal-dialysis-market

Further key findings from the study suggest:

• Hemodialysis dominates the industry with over 80.0% of the market share. These processes are performed in centers as well as in home settings primarily for adults. This enhanced applicability and benefits in comparison to peritoneal dialysis are expected to promote growth.
• Presence of treatment centers and skilled personnel in abundance to carry out procedures is expected to drive the growth for these services. Factors responsible for higher market share of services may be classified into rising number of centers, development of training courses for home-based patients, and rising number of patients requiring dialysis treatment.
• Home-based procedures are anticipated to witness the fastest growth over the forecast period. Development of small & portable systems along with with rising healthcare literacy amongst patients are vital impact rendering drivers.
• Regionally, Asia Pacific is predicted to contribute higher revenue share over the forecast period. Improving healthcare infrastructure, rising disposable income, and growing incidence of conditions such as diabetes within the region are expected to support growth.
• Players highlighted in the study include Fresenius Medical Care AG & Co. KGaA, NIPRO Medical Corporation, B. Braun Avitum AG, Baxter, and DaVita Inc. These companies are aggressively working toward purchasing dialysis centers or establishing new centers to cater to the rising demand.

Grand View Research has segmented the global hemodialysis and peritoneal dialysis market on the basis of type, product, end-use, and region:

Global Hemodialysis And Peritoneal Dialysis Type Outlook (Revenue, USD Million, 2014-2025)

• Hemodialysis
• Peritoneal Dialysis

Global Hemodialysis And Peritoneal Dialysis Product Outlook (Revenue, USD Million, 2014-2025)

• Device
• Consumables
• Services

Global Hemodialysis And Peritoneal Dialysis End-use Outlook (Revenue, USD Million, 2014-2025)

• Home-based
• Hospital-based

Hemodialysis And Peritoneal Dialysis Regional Outlook (Revenue, USD Million, 2014-2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Hyaluronic Acid Raw Material Market Overview, Analysis And Forecast To 2024

HA - No Laughing Matter, This…

Nowadays, everyone, be it man or woman, teenager or adult, is focused on keeping their skin glowing and fresh. You might have seen advertisements about anti-ageing and anti-wrinkle creams and lotions on the television. This is a burgeoning industry right now, as manufacturers have managed to strike a chord with consumers through their attractive product features. However, there are products that may cause more harm than good for the skin. This causes people to discard the product, and then search for the next one. However, unbeknownst to us, the answer to keeping our skin ever-youthful (as the ads promise!) lies within our body itself, and it is called hyaluronic acid (HA).

If you are confused by the name, and doubtful due to the presence of the term ‘acid’ in it, you can rest easy. For this product is found naturally in our skin, where it holds water and performs the critical function of keeping our skin plump and hydrated. While helping retain moisture, hyaluronic acid also prevents this moisture from evaporating into the air. However, as we get older, the proportion of this acid in our body decreases. Fruits and vegetables rich in antioxidants can help stimulate production of HA in our bodies. However, usage of hyaluronic acid raw material in skin products has gained much traction, as the anti-ageing movement intensifies. 

The Many Faces Of HA

The hyaluronic acid raw material market finds huge demand in a number of critical sectors. Its distinct properties are what have made it a sought-after product, not only in cosmetics but also in the pharmaceutical and medical industry. Some of the applications include:

• In Ophthalmology- It finds use as a viscoelastic tool for ophthalmological surgeries, owing to its unique physicochemical properties. HA is useful during cataract surgeries, as it facilitates procedures, while also protecting the corneal endothelium. Besides this, hyaluronic acid raw material also find use in other ophthalmic applications such as keratoplasty, retinal reattachment, trabeculectomy, as well as treatment to relieve ‘dry eye’ disease symptoms.
• In Dermatology- The acid is found in a number of skincare products that claim to combat wrinkles, and for good reason. Juvederm® and Restylane® are the two major dermal fillers that are used in wrinkle treatment. Wrinkles can be eliminated or temporarily reduced, with their effect lasting up to 1 year. Additionally, it is used to combat acne scars, while it is also very effective in cases of dry, cracked and thin skin.
• In Orthopedics - Hyaluronic acid is hugely effective in cases of osteoarthritis, and is taken by people who can’t use painkillers, or are unable to undergo total knee replacement surgery. Doctors refer to these injections as ‘viscosupplementation’. Studies have shown that it provides better results than painkillers in certain OA cases.
• In Medical Device Coatings - The product is used in hydrophilic coatingsfor a number of medical devices, which include catheters, sensors and guidewires. The device biocompatibility and lubricity can be improved, while also reducing tissue abrasion.
• In Drug Delivery - Hyaluronan formulations, as well as its derivatives, have been developed as injectable, topical and implantable vehicles for the localized, controlled delivery of biologically active molecules.
• In Surgical Adhesion Prevention - Adhesions may occur after abdominal operations, causing issues such as bowel obstruction, infertility, and chronic abdominal pain. A mechanical barrier composed of hyaluronic acid and carboxymethylcellulose is effective in preventing tissue adherence after abdominal surgeries.
• In Healing Wounds - HA helps in faster healing of wounds, by regulating inflammation levels and signaling the body that it build more blood vessels in the damaged area. Additionally, it has anti-bacterial properties and are effective at combating gum diseases. It has been observed that through its application, there has been a reduction in wound size and decrease in pain.

Some Trends & Statistics

The increasing women population of age 35 to 65 years across the globe engenders a greater demand for anti-aging cosmetic and aesthetic treatments. Owing to the distinctive viscoelastic and moisturizing properties coupled with lower toxicity levels offered by hyaluronic acid-based products, the demand for this polymer in dermal fillers is expected to grow. In addition, its application in the treatment of vesicoureteral reflux is anticipated to grow due to the minimally invasive nature of the involved procedures. Thus, it is anticipated that the need for hyaluronic acid-based products will serve as a high impact driver for the hyaluronic acid raw material market over the forecast period.

According to the International Society of Aesthetic Plastic Surgery, in 2018, there were approximately 23 million cosmetic procedures performed globally, of which nearly 3.8 million procedures were HA-based non-surgical ones. This represented a jump of 11.6% from 2017, with all other types, except botulinum toxin procedure, showing a downward trend. Some of the top countries recording a majority of the aesthetic treatments in 2018 were the U.S., Brazil, Mexico, Germany, India, Italy, Argentina, and Colombia. Medical tourism for cosmetic surgery in the U.S. plays a very important role in aiding the uptake of these products and procedures, which is expected to drive the hyaluronic acid raw material market in the coming few years.

According to the American Society for Aesthetic Plastic Surgery, in 2018, Americans spent approximately USD 17.4 billion on non-surgical procedures, of which USD 11.55 billion was spent on injectables, USD 2.83 billion was spent on facial rejuvenation procedures, while other non-surgical procedures such as hair removal and sclerotherapy saw expenditures worth around USD 3.04 billion.

To request a sample copy or view summary of this report, click the link below: https://www.grandviewresearch.com/industry-analysis/hyaluronic-acid-ha-raw-material-market

Recent Developments

Some of the key companies operating in the hyaluronic acid raw material market are Salix Pharmaceuticals; ALLERGAN; Lifecore Biomedical, LLC; Shiseido Co., Ltd.; Anika Therapeutics, Inc.; Smith & Nephew; Maruha Nichiro Corporation; Ferring B.V.; SEIKAGAKU CORPORATION; Genzyme Corporation; F. Hoffmann-La Roche Ltd.; Contipro a.s.; Zimmer Biomet, among others. Recent developments include:

• Anika Therapeuticscommenced the full commercial launch of its injectable HA-enhanced bone repair therapy, ‘TACTOSET’, in the United States, in December 2019. It has been developed for treating bone voids and other bone defects of the skeletal system caused due to age-related degeneration or trauma.
• Ferring Pharmaceuticalsannounced in November 2019 that Blue Cross Blue Shield of Michigan Medicare Advantage and Commercial patients will have EUFLEXXA access as a co-preferred brand starting January 1, 2020. The product is effective in combating osteoarthritis knee pain.
• In October 2019, Allergan launched three new OTC REFRESH® RELIEVA™ products - REFRESH® RELIEVA™, REFRESH® RELIEVA™ PF (preservative-free) multidose, and REFRESH® RELIEVA™ FOR CONTACTS. REFRESH® offers the only family of products in the United States that contain carboxymethylcellulose (CMC), hyaluronic acid (an inactive ingredient), glycerin, and HydroCell™ technology.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pacemaker Market Expected to Collect USD 10.3 Billion by the End of 2025

Life is the not only a most important thing, but also

To save and prolong this precious thing, man has gone over to achieve several feats with the help of science and technology, and has developed healthcare and life saving technology to such a level, that astonishes us to the core.

When we talk about heart pacemaker, we talk about the same level of developed healthcare technology, which is proving out to be a lifesaver in literal meaning. Pacemaker or ‘Artificial Cardiac Pacemaker’ was developed Wilson Greatbatch in 1958, along with the pacemakers batteries. And since it has been developed, it has helped multiple people prolong their lives. As of 2016, 1.14 million pacemakers are in use globally; and the numbers are going to rise to 1.43 million units by the year 2023. Therefore, the Global Pacemaker Market is certainly receiving great demand, which is expected to reach USD 10.3 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 7.2% CAGR.

Brief on Cardiac Pacemaker

Cardiac pacemaker is one of the cardiovascular medical devices, which controls the functioning of the heart using electrical impulses that artificially contract the heart muscles. A block in the heart’s electrical conduction system may result in failure of the natural pacemaker in the heart. It generates electrical impulses delivered by electrodes to cause the heart muscle chambers (the upper, or atria and/or the lower, or ventricles) to contract and therefore pump blood; by doing so this device replaces and/or regulates the function of the electrical conduction system of the heart.

Types

These artificial pacemakers are of two types, external and implantable. External pacemakers are used in case of emergencies with continuous monitoring in intensive care units at hospitals. External pacemakers also include wearable pacemakers, but due to portability and performance issues, these devices are rarely used. The benefit of the internal pacemakers over the external ones makes them the comfortable choice for the patient and can be aptly understood by the pie-chart below.  

                                                        

Implantable pacemakers are of the three types, single chamber, dual chamber, and biventricular, and are inserted through a simple surgery, using general anesthesia. In single chamber pacemakers, a single lead is implanted into one of the heart chambers, the atrium or the ventricle; while in dual chamber pacemakers, two leads are placed in the ventricle and the atrium. Dual chamber pacemaker functioning closely resembles that of the natural pacemaker present in the human body.

The biventricular pacemaker also known as Cardiac Resynchronization Therapy (CRT) is used in patients with a lack of synchronization between the contractions of the left and right ventricles, a condition known as ventricular dysynchrony. These devices consist of a couple of leads, one stimulates the septum and the other stimulates the epicardial wall of the left ventricle.

Request a free sample copy or view report summary: Pacemaker Market Report

Pacemakers: Technological Advancements

Following are a couple of advancements, which are likely to impact the dynamics of the global pacemaker market:

• Dynamic pacemaking technology: This technology is under development for its use in artificial hearts. Transitional tissue welding is required in artificial tissue implant technology, which utilizes stem cells or other cells.
• Microprocessor-controlled pacemakers: Kelvin II pacemaker is a dual chamber microprocessor-enabled pacemaker. This device has a microchip and pacer chip in an integrated circuit. Other specifications of this device include 4kB read only memory, 2kB random access memory, and 8-b microprocessor.
• Interconnecting Technology - With increasing trend of interconnectivity in the devices as the modern age is coming up, pacemakers are not to be left aside. With interconnectivity with outside devices possible, pacemakers can be easily monitored and its problems can be solved in no time to give a good leverage to the health of the patients.

Pacemaker: Market Snapshot

The key drivers impacting the growth of the pacemaker market include:

• Increasing incidence of Cardiovascular Diseases (CVDs)
• Technological advancement in pacemakers
• Availability of reimbursement for pacemaker implantation procedures

Above factors push the demands in the market and boost the competition, which leads to greater technological advancements along with research and development in the sector. New product development, geographical expansion, collaboration, mergers and acquisitions, and pricing strategies are key undertakings of players in this space. For Instance, in July 2016, St. Jude Medical received U.S. FDA approval for SyncAV, a CRT software compatible with the company’s multiPoint pacing technology. The software was approved in the European market in June 2016.

Some of the key players in the market are Medtronic; BIOTRONIK, Inc.; Boston Scientific Corporation; St. Jude Medical; ZOLL Medical Corporation; MEDICO S.p.A.; Vitatron; Pacetronix; and Cordis, Inc. among others.

Recent Developments

• A newbattery-less, wireless pacemaker was introduced over the summer by researchers from Rice University. It is designed to harvest energy wirelessly from radio-frequency radiation transmitted by an external battery pack. The device was designed to be implanted directly into a patient’s heart, removing the need for wires, known as “leads,” which can create complications with bleeding and infection.
• A team of engineers out of the University of Texas at San Antonio (UTSA) announced in May a new grant from the National Science Foundationto commercialize a new chip that can make lower power electronics like cell phone batteries and pacemaker devices run more efficiently.
• Alain Nogaret & his team from BATH University has developed physical models and small devices capable enough to predicting neuron behavior and reversing the effect of heart failure. This gives way for development of new line of pacemakers
• Researchers from Harvard’s school of engineering and applied sciences have created the world’s smallest radio receiver, a technology assembled from atomic-scale defects in pink diamonds. It could have the potential to help power the next generation of wireless pacemaker devices by transmitting electrical pulses without the need for leads.

Complementary & Alternative Medicine Market Is Expected To Accomplish A Valuation Of Around USD 296.3 Billion By 2027

Inhale the future, exhale the past….

So goes a saying in yoga, which means to embrace the present and what’s about to come, and leave the past behind and every baggage that came with it. It goes without saying that Yoga has widely come to be integrated into many a person’s daily routine, crossing the boundaries of both region, and religion. However, it is not only yoga that has captured the attention of the global citizen. Tai-chi, homeopathy, Ayurveda and reiki are some of the other phenomenon that have caught the world by storm. Exactly what are they, and how have they managed to convince people to practice them?

To answer simply, they are all forms that come under the concept of Complementary and Alternative Medicines (CAM). The next question would be, what exactly is this ‘CAM’? Simply put, complementary and alternative treatment include a number of traditional medicinal treatments where a disease is attended to with the help of organic products, natural methods, and faith healing. They are generally used in the treatment of chronic ailments and pains.

CAM - On A Blazing Trail…

Most prominent forms of complementary and alternative medicine in usage include application of ayurvedic medicine and naturopathic treatment, acupuncture, mind/body healing, yoga and magnetic intervention. Ayurveda and Naturopathic treatment involves usage of nature derived products that are believed to possess therapeutic properties for various medical conditions. Although the various forms of alternative medicine seem to be viable treatment options, they seldom have any documented and/or approved backing from any clinical data, and work on word-of-mouth and personal faith.

The complementary and alternative medicine market has been classified according to the medium of their application, that is, whether they are traditionally used, or body healing, external energy, mind healing, or through the use of diet and herbs. Another form of treatment is through the senses.

Traditional complementary and alternative medicine - Includes therapies and practices that have been practiced for centuries, and are more mainstream as compared to other CAM types. Examples are acupuncture, Ayurveda, homeopathy, naturopathy, and Chinese or Oriental medicine. 

Body healing - Is based on the idea that injury or illness in one area of the body adversely affects other bodily functions. Steps involve the use of manual manipulation so that the other body parts can be brought back to their normal functioning, which would allow full focus on the actual site of injury or illness. Often, body healing techniques are combined with those of the mind. Examples of this type include massage, tai chi, yoga, body movement therapies, and chiropractic & osteopathic medicine.

Diets and herbs - Today’s society is plagued with health issues on account of the shift towards food substances that are rich in oils, fats and complex carbohydrates. Previously, a person’s diet simply consisted of fruits, meat, vegetables and grains, which provided high nutritional value to the body. That is why this complementary and alternative medicine technique is making a big return, especially among the current working population who really need to maintain their physique and health. The approach includes herbal medicines, dietary supplements and nutrition/diet.

External Energy - It is an age-old ad popular belief that external energies from various sources have a direct bearing on a person’s health. Techniques such as electromagnetic therapy, Reiki and Qigong help in quietening the mind and removing and releasing the blocked energies, thus helping the body, mind and spirit to reach balance and harmony.

Mind - A healthy mind resides in a healthy body, it is said. There’s no better way to put forth the dependence that one has on other. This is even recognized by conventional science, and studies have proved that the healing process is faster and smoother if a person has positive emotional and mental health. Meditation, biofeedback and hypnosis are some of the techniques that are involved in the exercise of the mind.

Senses - A relatively different approach in the complementary and alternative medicine market that makes use of art, dance and music forms, as well as visualization and guided imagery, to improve overall health. This technique makes use of the five human senses of touch, sight, hearing, taste and smell.

Alternative Medicine and Advancements

These treatment forms have a history that dates a long way back into time and a number of them have documented origins in key Asia Pacific countries like India, China, and Japan. The techniques were limited to Asian countries for a considerable amount of time; however, they have rapidly gained popularity almost all over the world. Earlier, the practitioners of complementary and alternative medicines were considered as quacks; however, now it is rapidly being recognized across the globe as a genuine practice, with licensing being applied in this space.

A study by the National Center for Health Statistics (NCHS) and the NCCIH in 2017 found that in the United States:

• Adults showed an increase in the usage of complementary health practices, when compared to 2017.
• Yoga, meditation and chiropractorvisits all witnessed a rise in these five years, with meditation showing a three-fold increase from 4.1% in 2012 to 14.2% in 2017.
• Gender-wise, all of these alternative complementary and alternative medicine approaches have seen a higher acceptance in the female population of the country, with yoga showing the highest disparity in terms of percentage adoption in males and females (6% for males vs. 19.8% for females).

Alternative medicines have seen both support and opposition in every country. Several governments are taking steps to introduce alternative medicine as legal form to improve lives of people. For instance, the government of India launched the “AYUSH” ministry in 2014 that is expected to support and develop alternative forms of medicine and improve the medical tourism in the field of alternative medicine. The department saw huge allocation of funds in the 2017-18 budget, to the tune of ₹ 1428.7 crore. Several scientific bodies are striving to develop scientific support for the claims made by naturalists and followers claiming the medical effects of complementary and alternative medicine.

There have also been many incidents where complementary and alternative medicine practices have been used illegally, as in a recent case of a practitioner in the U.S. state of Virginia who was caught practicing without a license, leading to him being sentenced to 12 months in jail. Also, with the growing threat of coronavirus, there has been a boom in the number of false claims about alternative medicines helping in combating the virus without any substantiated proof, which is harming the image of genuine complementary and alternative medicine practices.

To request a sample copy or view summary of this report, click the link below: https://www.grandviewresearch.com/industry-analysis/complementary-alternative-medicine-market

Complementary And Alternative Medicine: Market Snapshot

A recent report by Grand View Research has projected the complementary and alternative medicine market to be worth USD 296.3 billion by 2027, progressing at an astonishing CAGR of almost 20%. The key drivers impacting the growth of this industry include:

• Increasing adoption of alternative medicine across developing countries
• China and India have heavily contributed to the growth of the Asia Pacific region, and are expected to continue generating major revenue
• A rapid rise in the number of trained physicians in complementary and alternative medicine space is expected to shift patient preference towards these forms of treatment
• Integration of technological advancements
• Government initiatives to improve and provide scientific back-up

We have segmented the Complementary And Alternative Medicine market based on intervention type for which it is used:

Botanicals (Ayurveda, Naturopathy and Homeopathy), Acupuncture, Mind, Body & Yoga and Magnetic Intervention. Botanicals held a significant share in 2019 and are likely to grow at a steady CAGR over the forecast years, while magnetic intervention has been projected to show fastest growth through 2027.

The market is also segmented on the basis of distribution channels, into direct sales, e-sales and distance correspondence, wherein direct sales have dominated with almost three-quarters of the market share.

Some of the major complementary and alternative medicine market players include Nordic Nutraceuticals, Columbia Nutritional, Ramamani Iyengar Memorial Yoga Institute, Herb Pharm, John Schumacher Unity Woods Yoga Centre, Pure Encapsulations, LLC., The Healing Company Ltd, AYUSH Ayurvedic Pte Ltd, and Sheng Chang Pharmaceutical Company.

The U.S. state of Los Angeles saw a listing platform called “WellSet” being launched in March 2020, which caters to the alternative and holistic healthcare market. The service makes it easy for customers to find acupuncturists, therapists, nutritionists, life coaches and the likes for their line of complementary and alternative medicine treatment.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Structural Heart Devices Market Trends, Company Share, Industry Growth And Future Scope

It’s a well-known fact that heart defects have gripped a large proportion of the world population, as the harms of following unhealthy lifestyle habits have started to take a toll on people’s health. With surgeries related to structural heart diseases on the rise, structural heart devices have proved mightily helpful in medical scenarios.

Some Quick Facts….

• Nearly 5 million Americanscurrently are suffering from congestive heart failure. Approximately 550,000 new cases of CHF are discovered in the S. each year.
• A report by the American Heart Associationstated that 1 out of 3 Americans in 2016 succumbed to cardiovascular diseases, of which CHD and heart failure were responsible for more than half of those deaths.
• Nearly one out of 100 births(i.e., 40000 births) in the United States every year is affected with CHD, with one-fourth of these babies suffering from critical CHD.
• Diseases of the heart have been the major cause of deaths not only in the US, but also worldwide, with WHO stating them as the leading global cause of death. The total number of people who succumbed to CVDs stood at 17.9 million in 2016 globally

All these figures are indeed a cause of concern for us common citizens. A good proportion of the global population is focused on following a healthy lifestyle. However, still more are stuck on an unhealthy one, which act as an open invitation to such diseases. Most structural heart conditions are congenital, but they may also be acquired later in life.

Structural Heart Devices Have Opened New Avenues In Treatment

Till some time back, the way of treatment for such conditions was an open heart surgery. However, catheterization has since surpassed it. The presence of the structural heart devices market has provided surgeons the advantage of performing minimally invasive procedures. Transcatheter procedures are preferred over open-heart surgeries due to advantages such as lesser recovery time and procedural risk. It also avoids cardiopulmonary bypass, which reduces risk, thereby giving enhanced patient care. Operator expertise adds to the improved results of these procedures as compared to open-heart procedures. Also, patients incur less expenses owing to the shorter stay in the hospital.

Positive clinical evidence of structural heart devices are resulting in their increased use in the treatment of CHD. Similarly, other data supporting the results such as the STS National Database and American Heart Association Abstracts also encourage surgeons to conduct these procedures. Guidelines by the American College of Cardiology, American Stroke Association, and American Heart Association also standardize the procedures, thereby reducing the intraoperative risks and improve the outcomes of the surgeries.

Types Of Structural Heart Devices

Structural heart devices are classified into four types - surgical aortic valve replacement (SAVR), transcatheter aortic valve replacement (TAVR), mitral repair, and left atrial appendage closure (LAAC).

• Surgical aortic valve replacement (SAVR)- It is a type of open heart surgery that is performed in order to replace a diseased aortic valve. Typically, the process is more invasive than TAVI and need the patient to be placed on a heart and lung machine, under general anesthesia.
• Transcatheter aortic valve replacement (TAVR)- This is a minimally invasive procedure for replacing a narrowed aortic valve that does not open properly (aortic valve stenosis). TAVR is also known as transcatheter aortic valve implantation (TAVI). It can be performed on patients at intermediate or high risk of complications from SAVR, as well as certain people who cannot undergo open heart surgery.
• Mitral repair- Also known as annuloplasty. It is a procedure for tightening or reinforcing the annulus around a heart valve. The procedure can be performed during open-heart surgery as well as minimally-invasive heart surgery.
• Left atrial appendage closure(LAAC) - A procedure that closes the opening of the left atrial appendage. This is recommended in cases of atrial fibrillation, wherein the blood cannot be effectively squeezed out from the left atrium, leading to its collection in the left atrial appendage, increasing chances of a stroke.

To request a sample copy or view summary of this report, click the link below: https://www.grandviewresearch.com/industry-analysis/structural-heart-devices-market

Shining A Light On The Structural Heart Device Market Scenario

Aging population is driving the overall healthcare segment across the globe. Moreover, increasing focus on the quality of life of this group is further boosting the health care space, which extends to the structural heart devices industry. Cardiac disorders are highly common and people are aware of the consequences and readily seeking treatments for the same. These defects may be present at birth or may occur late in life due to wear & tear of the tissues. This adds to the already existing lifestyle diseases related to heart and results in occurrence of stroke. Thus, operations to reduce the risk of stroke are gaining roots in the market, which is expected to drive the structural heart devices market.

Asia Pacific is expected to be the most lucrative region for the industry. This can be attributed to the rapidly increasing geriatric population, presence of a large patient base, growing awareness & increased healthcare expenditure, and efforts of industry players to enter the market by introducing new products. North America held the largest share in the structural heart devices market in 2016, while it is expected to maintain its dominance over the coming years, with a strong preference for minimally invasive procedures factoring in its growth in the region. 

Competitors Stepping Up Their Game

Several regional and international players are operating in the structural heart devices market. Some of the key players are Biomerics, Boston Scientific Corporation, Medtronic, CardioKinetix, Edwards Lifesciences Corporation, Abbott Laboratories, LivaNova PLC, Comed BV, JenaValve Technology, Inc., and ST. JUDE MEDICAL. Key developments that the structural heart devices industry has seen in the past year include:

• In December 2019, Biomericsand ATL Technology dissolved their joint venture Biomerics ATL LLC, with the former purchasing ATL Technology’s interests in the JV. The business unit will be renamed as Biomerics CRI. The Biomerics ATL JV began with the asset acquisition of CRI Medical, and its facilities in Indiana and Costa Rica in 2018.
• In August 2019, the US FDAapproved Medtronic’s Evolut™ Transcatheter Aortic Valve Replacement (TAVR) system for patients with symptomatic severe native aortic stenosis, who are at a low risk of surgical mortality. The approval comes on the back of a multi-center Evolut Low Risk Trial that monitored and evaluated 3 valve generations in more than 1400 patients.
• In March 2019, Boston Scientificreceived the CE Mark for its next-generation WATCHMAN FLX™ Left Atrial Appendage Closure Device, paving way for a limited market release in Europe. The device is intended to reduce stroke risk in people with non-valvular AF.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biotechnology Market to Account for USD 727.1 Billion by 2025

Buddha is quoted as saying that “Change is the only constant thing in life” and everybody knows that a growling engine of change in modern age is - Technology. It has the potential to build upon existing systems or completely overthrow redundant tech and substitute them with a modern efficient technology. Biotechnology is one of the shining examples of this phenomenon and will continue to be so until a long time.

What Exactly is Biotechnology?

‘Biotechnology’ is the broad area of biology, involving living systems and organisms and deals with biological processing of those living organisms & systems to develop new technologies. It also exploits cellular & biomolecular processes to create new products & technologies. This leads to improvement in the health of consumers and the planet boosting the growth of Biotechnology market. Along with many things, it also deals with Tissue engineering, DNA sequencing and Nanobiotechnology.

Biotechnology covers broad aspects in the utility arena. Although, it is used in several field, its apt usage is in four sectors, namely, Health care (Medical), Crop production and Agriculture, Non-food (Industrial) uses of crops and other products (e.g. biodegradable plastics, vegetable oil, biofuels), and Environmental uses.

For example, one application of biotechnology is the directed use of microorganisms for the manufacture of organic products (examples include beer and milk products). Another example is using naturally present bacteria by the mining industry in bioleaching. Biotechnology is also used to recycle, treat waste, clean-up sites contaminated by industrial activities (bioremediation), and also to produce biological weapons.

Its Role

Biotechnology is rooted in the science of microbiology, genetics, animal cell culture, embryology, cell biology, etc. The technology provides breakthroughs, developments, and products in biofuels, agricultural biotechnology, regenerative medicines, vaccines, and so on.

Biologists study cell functions & structure to get a better understanding of proteins, genes, and cells. The same helps fight orphan diseases, reduces carbon footprints, and provides cleaner energy. In addition, products developed from the technology boosts food sources, combats pollution, and improves nutritional health.

Its role in following sectors is quite prominent.

Healthcare (Medical): Biotechnology has been leveraged by the R&D professionals to bring more efficiency to medical practice and invade into arenas untouched by medicine. Technologies like Bioinformatics, Nanobiotechnology and DNA sequencing among others, has been of a big help. For example, Biotechnology has contributed to the discovery and manufacturing of traditional small molecule pharmaceutical drugs as well as drugs that are the product of biotechnology – biopharmaceutics. Modern biotechnology can also be used to manufacture existing medicines relatively easily and cheaply.

When it comes to health, genetic modification by biotechnology is also something to be highlighted. It has been applied in modifying the genetic structure of Mosquitoes (GM), resulting in the increase of capability to fight the outbreaks of harmful vector-borne diseases like Zika, Dengue and Malaria etc.

Crop production and Agriculture: Genetically Modified (GM) crops are developed with the help of biotechnology and has proved its worth in raising the yield of crops in the countries battling hunger and poverty. For example, Countries; like Burkina Faso, Nigeria, Egypt, South Africa, and Sudan are cultivating genetically engineered crops; such as Bacillus thuringiensis (Bt) cotton, corn, cow pea, nitrogen, water efficient rice, etc. Apart from this, scientists have also developed 3-D printed biotechnological CellPods that incubate seeds and accelerate their growth (with the help of adequate sunlight, air, & nutrition).

Non-Food (Industrial) Uses: Biotechnology is used in industries worldwide to develop several products, i.e.textile, fermented food products, paper and pulp, detergents as well as chemicals among others. Also, Genetically Modified Organisms (GMOs)

have been developed to enhance the diversity of applications and economic viability of industrial biotechnology.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/biotechnology-market

Nowadays to alleviate the problems of growing plastic waste, Biotechnology is also being leveraged to develop biodegradable plastics. This provides a huge push to the climate change initiative.

Environmental Uses: - With growing concerns regarding the environment nowadays, countries are looking towards biotechnology for new developments and remedies and biotechnology answers! Bioremediation is a fine example of leveraging biological organisms to treat waste and oil spillage in the seas and oceans.

How is the market faring?

The global biotechnology market size is expected to reach USD 727.1 billion by 2025, at a CAGR of 7.4%. This shows the amount of potential this market has in the current time. The key players in the markets are putting pedal to the metal and investing heavily to cater to the growing need of biotechnological demands.

Key players are Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, Pfizer, Merck & Co., and Sanofi among others. Mergers, collaborations, and manufacturing activities are the key strategies adopted by them to gain shares.

Recent Developments

• San Diego’s Eurofins Discoveryand Shanghai-based PharmaResources are joining forces to combat issues of lack of speed and efficiency in drug development arena.
• Sanofi's BTK inhibitor SAR442168 hit the primary endpoint in trial of relapsing multiple sclerosis patients, emboldening the French pharma to plot out a broad phase 3 program.
• Rochereported data from the spinal muscular atrophy trial it hopes will establish it as a rival to Biogen and Novartis in the disease.
• MaaT Pharmahas raised an €18 million ($20 million) series B round. The financing equips MaaT to wrap up a phase 2 trial of its lead microbiome therapy in graft-versus-host disease (GVHD) while expanding into solid tumors.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Market For Project Portfolio Management Industry to Witness Tremendous Growth and Expansion by 2027

Project Portfolio Management Market Growth & Trends

The global project portfolio management market size is anticipated to reach USD 11.4 billion by 2027, registering a CAGR of 13.4% from 2020 to 2027, according to a new report by Grand View Research, Inc. Growing trend of bring your own device (BYOD) among businesses is expected to improve employee productivity and real-time project monitoring, thereby, making it feasible to implement project portfolio management (PPM) solutions. Multi-regional businesses are fueling the demand for project portfolio management solutions to foster effective decision-making and prevent complexities. Extensive use of PPM solutions in data analytics to offer convenient services to customers at low costs in the BFSI and IT and telecom sectors is anticipated to drive the market growth.

The global rise in urbanization and digitization has made businesses to switch toward using technology driven solutions to meet the rapid pace of business growth. Emerging businesses that adopt cloud-based services, mainly in developing economies such as Asia Pacific, are expected to fuel the PPM market growth over the forecast period. Furthermore, facilities such as low setup costs, improved security, and increased collaboration opportunities, provided by the cloud-based solutions are expected to increase business productivity and overall growth of an organization.

Project-intensive organizations across different industry verticals have recognized the advantages of the PPM solution and have employed it to automate and simplify several operations and efficiently manage project lifespan. The PPM solution offers managers and organizations with the capability to see the big picture, confirming the use of best practices, principles, solutions, and standards during the project lifespan. For organizations handling multiple simultaneous projects, the PPM solution allows the right set of resources to complete them on defined budget and deadline. Thus, the benefits offered by PPM solutions are propelling the growth of this market.

Access Research Report of Project Portfolio Management Market@ Project Portfolio Management Market Report

Project Portfolio Management Market Report Highlights

• With the evolving business requirements, customers are looking for innovative solutions and services to manage their IT infrastructure, leading to companies adopting various support services. Hence, the service segment is anticipated to grow at a faster pace by 2027
• The cloud management segment is anticipated to witness high adoption over the forecast period, as the deployment of cloud-based solutions stimulates easy service delivery owing to their virtual presence that aids organizations in accessing data anytime, across connected devices
• The Small and Medium Enterprise (SME) segment is expected to witness a high growth rate over the forecast period owing to rapid growth of SMEs in emerging economies such as India and China and increasing proliferation of IT services
• The BFSI segment is expected to grow at a rapid rate over the forecast period due to increasing complexity in banking operations owing to increased multi-regional operations and outsourcing activities
• The project portfolio management market demand in Asia Pacific region is anticipated to grow remarkably by 2027, due to emerging SMEs and increasing adoption of BYOD culture in the region
• The key industry participants include Broadcom; Celoxis Technologies Pvt. Ltd.; Changepoint Corporation; HP Development Company, L.P.; ServiceNow; Planview Corporation; Planisware; Microsoft; Oracle; and Workfront, Inc.

Project Portfolio Management Market Segmentation

Grand View Research has segmented the global project portfolio management market based on offering, deployment, enterprise size, end use, and region:

Project Portfolio Management Offering Outlook (Revenue, USD Million, 2016 - 2027)

• Software
• Service
  • Integration & Deployment
  • Support & Maintenance
  • Training & Consulting

Project Portfolio Management Deployment Outlook (Revenue, USD Million, 2016 - 2027)

• Cloud
• On-premise

Project Portfolio Management Enterprise Size Outlook (Revenue, USD Million, 2016 - 2027)

• Large Enterprise
• Small & Medium Enterprise

Project Portfolio Management End-Use Outlook (Revenue, USD Million, 2016 - 2027)

• BFSI
• Government
• Engineering & Construction
• Healthcare
• IT & Telecom
• Others

Project Portfolio Management Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Automotive Embedded Telematics Market to Partake Significant Development During 2018 to 2025

The global automotive embedded telematics market size is expected to attain a valuation of USD 37.69 billion by 2025, according to a study conducted by Grand View Research, Inc. It is anticipated to expand at a CAGR of 20.9% over the forecast period. Increased demand for real-time vehicle tracking and advanced driver safety features are some of the factors expected to drive the market growth.

The automotive embedded telematics market is expected to witness significant growth over the forecast period on account of the provision of customization options such as bundled packages, pay-per-use services, and premium subscription services. Moreover, government regulations such as eCall by the European Union (EU) in 2018, CONTRAN 245 by Brazil in 2013, and ERA-GLONASS by Russia in 2013 have encouraged the adoption of these systems.

The increasing volumes of passenger and commercial vehicles and demand for improved in-vehicle connectivity in the Asia Pacific region are expected to accelerate the market growth. The installation/inclusion of features such as automatic collision notifications, hands-free calling, and driver assistance in connected passenger and commercial vehicles further encourages the growing adoption of automotive embedded telematics systems. Introduction of navigation services, along with the implementation of data services such as application-based services, content management, among others are anticipated to further fuel the demand in near future.

Stringent government regulations concerning the safety of passengers have necessitated Original Equipment Manufacturers (OEMs) to install security systems in vehicles. The European Union mandated the inclusion of an eCall alarm system in all passenger cars and light commercial vehicles produced post May 2018. The regulation applies to all new cars manufactured in Europe. In addition to instantaneous deployment of airbags, the eCall system automatically places a call to an emergency response center in the event of an accident or other emergencies. The GPS installed in the car is used to determine the vehicle’s location to facilitate immediate deployment of emergency assistance to that location. Such favorable government policies are anticipated to contribute to the market expansion in the forthcoming years.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/automotive-embedded-telematics-market

Further key findings from the study suggest:

• Automotive manufacturers are apportioning considerable investment capital and dedicating company resources towards developing autonomous vehicles. This is anticipated to lead to a subsequent rise in the adoption of automotive embedded telematics systems
• Key companies in North America including Verizon and Mix Telematics are developing various advanced solutions in the automotive embedded telematics market and thus expected to encourage regional market growth in near future
• Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period and is projected to reach USD 13.0 billion by 2025
• The key market participants include Ford Motor Company, Continental AG, General Motors, TomTom Telematics BV, Hyundai Motor Company, Toyota Motor Corporation, MiX Telematics International Ltd., INFINITI Motor Company Ltd., BMW AG, and Verizon Connect, to enumerate a few.

Grand View Research has segmented the global automotive embedded telematics market based on component, solution, application, and region:

Automotive Embedded Telematics Component Outlook (Revenue, USD Million, 2014 - 2025)

• Hardware
• Service
• Connectivity

Automotive Embedded Telematics Solution Outlook (Revenue, USD Million, 2014 - 2025)

• Safety & Security
• Information & Navigation
• Entertainment
• Remote Diagnostics

Automotive Embedded Telematics Application Outlook (Revenue, USD Million, 2014 - 2025)

• Passenger Cars
• Commercial Vehicles

Automotive Embedded Telematics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa (MEA)

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.